NCT00572325
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- MAASTRO clinic, Maastricht Radiation Oncology Maastricht, Netherlands
Clinical trial condition
Non-small Cell Lung Cancer
Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.
1,362 public trials
335 recruiting studies
Non-small Cell Lung Cancer trial results
Completed
Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen
NCT00316225
- Conditions
- Adenoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +13 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Copenhagen, Denmark
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hanover, Germany
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain
NCT01000740
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Research Site Beijing, Beijing Municipality, China
- Research Site Guangzhou, Guangdong, China
- Research Site Wuhan, Hubei, China
- Research Site Nanjing, Jiangsu, China
NCT00113516
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Pfizer Investigational Site Los Angeles, California, United States
- Pfizer Investigational Site Newark, Delaware, United States
- Pfizer Investigational Site Newark, Delaware, United States
- Pfizer Investigational Site Wilmington, Delaware, United States
NCT01124253
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- The Lung Cancer Center of shanghai chest Hospital Shanghai, China
NCT00318136
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
Not specified
Completed
Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)
NCT00097227
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- ImClone Investigational Site Los Angeles, California, United States
- ImClone Investigational Site Santa Monica, California, United States
- ImClone Investigational Site Newark, Delaware, United States
- ImClone Investigational Site Orlando, Florida, United States
Completed
Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)
NCT00097214
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- ImClone Investigational Site Bentonville, Arkansas, United States
- ImClone Investigational Site Tucker, Georgia, United States
- ImClone Investigational Site Evanston, Illinois, United States
- ImClone Investigational Site Louisville, Kentucky, United States
NCT00569114
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Comprehensive Blood and Cancer Center Bakersfield, California, United States
- City of Hope Duarte, California, United States
- University of Southern California Los Angeles, California, United States
- University of California at Davis Sacramento, California, United States
NCT00103831
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Local Institution Denver, Colorado, United States
- Local Institution Rochester, Minnesota, United States
- Local Institution Toronto, Ontario, Canada